Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1244-1251

  Lewis, Timothy A ^a,b   Munson, Albert E ^a   McCoy, Kathleen L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GALLIUM ARSENIDE;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; ELECTRONICS INDUSTRY; IMMUNOCOMPETENCE; IMMUNOTOXICITY; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEMICONDUCTOR; SPLEEN SIZE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ARSENICALS; CD4-POSITIVE T-LYMPHOCYTES; GALLIUM; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYBRIDOMAS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C3H; MICE, INBRED DBA; PEPTIDES; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS;

EID: 0030426841     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. ASHWELL, J. D., FOX, B. S. AND SCHWARTZ, R. H.: T cell recognition of antigen and Ia molecules involves a trimolecular complex. In Processing and Presentation of Antigens, ed. by B. Pernis, S. C. Silverstein and H. J. Vogel, pp. 273-290, Academic Press, San Diego, CA, 1988.
2. AVILÉS, F. X.: Innovations in Proteases and Their Inhibitors, Walter de Gruyter, Inc., Hawthorne, NY, 1993.
3. BAKER, P. E., GILLIS, S. AND SMITH, K. A.: Monoclonal cytolytic T cell lines. J. Exp. Med. 149: 273-278, 1979.
4. BURNS, L. A., SIKORSKI, E. E., SAADY, J. J. AND MUNSON, A. E.: Evidence for arsenic as the immunosuppressive component of gallium arsenide. Toxicol. Appl. Pharmacol. 110: 157-169, 1991.
5. COFFMAN, R. L. AND WEISSMAN, I. L.: B220: a B cell-specific member of the T200 glycoprotein family. Nature 289: 681-683, 1981.
6. CORRADIN, G. AND HARBURY, H. R.: Cleavage of cytochrome c by cyanogen bromide. Biochim. Biophys. Acta 22: 489-502, 1970.
7. DIALYNAS, D. P., QUAN, Z. S., WALL, K. A., PIERRES, A., QUINTÁNS, J., LOKEN, M. R., PIERRES, M. AND FITCH, F. W.: Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu- 3/T4 molecule. J. Immunol. 131: 2445-2451, 1983.
8. GERMAIN, R. N.: The ins and outs of antigen processing and presentation. Nature 322: 687-689, 1986.
9. GERMAIN, R. N.: MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76: 287-299, 1994.
10. GUILLET, J. G., LAI, M. Z., BRINER, T. J., BUUS, S., SETTE, A., GREY, H. M., SMITH, J. A. AND GEFTER, M. A.: Immunological self, nonself discrimination. Science 235: 865-870, 1987.
11. HARRISON, R. J.: Gallium arsenide: State of the art reviews. Occup. Med. 1: 49-58, 1986.
12. HOLSAPPLE, M. P., TUCKER, A. N., MCNERNEY, P. J. AND WHITE, K. L.: Effects of N-nitrosodimethylamine on humoral immunity. J. Pharmacol. Exp. Ther. 229: 493-500, 1984.
13. JENKINS, P. P., MACINNES, A. N., TABIB-AZAR, M. AND BARRON, A. R.: Gallium arsenide transistors: Realization through a molecularly designed insulator. Science 263: 1751-1753, 1994.
14. JENSEN, P. E.: Reduction of disulfide bonds during antigen processing: Evidence from a thiol-dependent insulin determinant. J. Exp. Med. 174: 1121-1130, 1991.
15. JENSEN, P. E.: Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J. Immunol. 150: 3347-3356, 1993.
16. KAMINSKI, N. E. AND HOLSAPPLE, M. P.: Inhibition of macrophage accessory cell function in casein-treated B6C3F1 mice. J. Immunol. 139: 1804-1810, 1987.
17. LAH, T. T., HAWLEY, M., ROCK, K. L. AND GOLDBERG, A. L.: Gamma-interferon causes a selective induction of lysosomal proteases, cathepsins B and L, in macrophages. FEBS Lett. 363: 85-89, 1995.
18. LAM, K. P. AND STALL, A. M.: Major histocompatibility complex class II expression distinguishes two distinct B cell developmental pathways during ontogeny. J. Exp. Med. 180: 507-516, 1994.
19. LANIER, L. L., GUTMAN, G. A., LEWIS, D. E., GRISWOLD, S. T. AND WARNER, N. L.: Monoclonal antibodies against rat Ig Kappa chains. Hybridoma 1: 125-131, 1982.
20. LEDBETTER, J. A. AND HERZENBERG, L. A.: Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47: 63-90, 1979.
21. MCMASTER, W. R. AND WILLIAMS, A. F.: Identification of Ia glycoproteins in rat thymus and purification from rat spleen. Eur. J. Immunol. 9: 426-433, 1979.
22. MEGO, J. L.: Role of thiols, pH and cathepsin D in the lysosomal catabolism of serum albumin. Biochem. J. 218: 775-783, 1984.
23. MERKEL, B. J., MANDEL, R., RYSER, H. J.-P. AND MCCOY, K. L.: Characterization of fibroblasts with a unique defect in processing antigens with disulfide bonds. J. Immunol. 154: 128-136, 1995.
24. MISHELL, R. I. AND DUTTON, R. W.: Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126: 423-442, 1967.
25. OZATO, K., MAYER, N. AND SACHS, D.: Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124: 533-540, 1981.
26. PÄTZOLD, S., SCHMIDT, A. AND SEIDEL, A.: Loss of cathepsin B activity in alveolar macrophages after in vitro quartz phagocytosis. J. Toxicol. Environ. Health 40: 547-554, 1993.
27. RABIN, H., HOPKINS, R. F., RUSCETTI, F. W., NEUBAUER, R. H., BROWN, R. L. AND KAWAKAMI, T. G.: Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J. Immunol. 127: 1852-1856, 1981.
28. ROBINSON, A. L.: GaAs readied for high-speed microcircuits. Science 219: 275-277, 1983.
29. RODRIQUEZ, G. M. AND DIMENT, S.: Role of cathepsin D in antigen presentation of ovalbumin. J. Immunol. 149: 2894-2898, 1992.
30. ROSNER, M. H. AND CARTER, D. E.: Metabolism and excretion of gallium arsenide and arsenic oxides by hamsters following intratracheal instillation. Fundam. Appl. Toxicol. 9: 730-737, 1987.
31. SAMELSON, L. E., GERMAIN, R. N. AND SCHWARTZ, R. H.: Monoclonal antibodies against the antigen receptor on a cloned T cell hybrid. Proc. Natl. Acad. Sci. U.S.A. 780: 6972-6976, 1983.
32. SHIMONKEVITZ, R., COLON, S., KAPPLER, J. W., MARRACK, P. AND GREY, H. M.: Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J. Immunol. 133: 2067-2074, 1984.
33. SIKORSKI, E. E., MCCAY, J. A., WHITE JR., K. L., BRADLEY, S. G. AND MUNSON, A. E.: Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam. Appl. Toxicol. 13: 843-858, 1989.
34. SIKORSKI, E. E., BURNS, L. A., MCCOY, K. L., STERN, M. L. AND MUNSON, A. E.: Suppression of splenic accessory cell function in mice exposed to gallium arsenide. Toxicol. Appl. Pharmacol. 110: 143-156, 1991a.
35. SIKORSKI, E. E., BURNS, L. A., STERN, M. L., LUSTER, M. I. AND MUNSON, A. E.: Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response. Toxicol. Appl. Pharmacol. 110: 129-142, 1991b.
36. SPRINGER, T. A., GALFRÉ, G., SECHER, D. S. AND MILSTEIN, C.: Mac-1: A macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9: 301-306, 1979.
37. SQUIBB, K. S. AND FOWLER, B. A.: The toxicity of arsenic and its compounds. In Biological and Environmental Effects of Arsenic, ed. by B. A. Fowler, pp. 233-269, Elsevier, Amsterdam, 1983.
38. UNANUE, E. R. AND ALLEN, P. M.: The basis for immunoregulatory role of macrophages and other accessory cells. Science 236: 551-557, 1987.
39. VAN DEH DRIFT, A. C. M., VAN NOORT, J. M. AND KRUSE, J.: Catheptic processing of protein antigens: Enzymatic and molecular aspects. Semin. Immunol. 2: 255-272, 1990.
40. VIDARD, L., ROCK, K. L. AND BENACERRAF, B.: Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases. J. Immunol. 149: 498-504, 1992.
41. WEBB, D. R., WILSON, S. E. AND CARTER, D. E.: Comparative pulmonary toxicity of gallium arsenide, gallium (III) oxide, or arsenic (III) oxide intratracheally instilled into rats. Toxicol. Appl. Pharmacol. 82: 405-416, 1986.
42. YAMAUCHI, H., TAKAHASHI, K. AND YAMAMURA, Y.: Metabolism and excretion of orally and intraperitoneally administered gallium arsenide in the hamster. Toxicology 40: 237-246, 1986.
43. ZEIGLER, H. K. AND UNANUE, E. R.: Decrease in macrophage antigen catabolism by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc. Natl. Acad. Sci. U.S.A. 79: 174-185, 1982.